Align 3-phosphoshikimate 1-carboxyvinyltransferase (EC 2.5.1.19) (characterized)
to candidate WP_011388048.1 RRU_RS01545 3-phosphoshikimate 1-carboxyvinyltransferase
Query= BRENDA::Q9R4E4 (455 letters) >NCBI__GCF_000013085.1:WP_011388048.1 Length = 451 Score = 481 bits (1237), Expect = e-140 Identities = 265/447 (59%), Positives = 306/447 (68%), Gaps = 9/447 (2%) Query: 8 RPATARKSSGLSGTVRIPGDKSISHRSFMFGGLASGETRITGLLEGEDVINTGKAMQAMG 67 RP A +S+ LSG +R+PGDKSISHR+ M GGLA G T I GLLEGEDVI T AM+AMG Sbjct: 8 RPLRAHRSTPLSGRIRVPGDKSISHRALMLGGLAVGRTEIRGLLEGEDVIATAHAMEAMG 67 Query: 68 ARIRKE-----GDTWIIDGVGNGGLLAPEAPLDFGNAATGCRLTMGLVGVYDFDSTFIGD 122 ARI ++ W +DGVG GGL P LD GNA TG RL MGL+ +D + GD Sbjct: 68 ARIDRQETADGAGVWTVDGVGVGGLAEPADVLDMGNAGTGARLLMGLLATHDLTAILTGD 127 Query: 123 ASLTKRPMGRVLNPLREMGVQVKSEDGDRLPVTLRGPKTPTPITYRVPMASAQVKSAVLL 182 ASL RPM RV +PL G G RLP+ +RG TP P++YRVP+ SAQVKSAVLL Sbjct: 128 ASLRGRPMKRVTDPLALFGASFVGRSGGRLPMAVRGTATPLPVSYRVPVPSAQVKSAVLL 187 Query: 183 AGLNTPGITTVIEPIMTRDHTEKMLQGFGANLTVETDADGVRTIRLEGRGKLTGQVIDVP 242 AGLNTPG TTVIEP+ TRDHTE+ML FGA L + D G TI L G+ +L ++VP Sbjct: 188 AGLNTPGETTVIEPVATRDHTERMLGHFGAALRLGRDDQGATTITLTGQPELRAAPVEVP 247 Query: 243 GDPSSTAFPLVAALLVPGSDVTILNVLMNPTRTGLILTLQEMGADIEVINPRLAGGEDVA 302 DPSS AFPLVAA+LVP S VT+ V MNP R GLI TL+EMGADI + +PR+ GE VA Sbjct: 248 ADPSSAAFPLVAAVLVPESHVTLAGVGMNPQRIGLIDTLREMGADILIRDPRIEAGEPVA 307 Query: 303 DLRVRSSTLKGVTVPEDRAPSMIDEYPILAVAAAFAEGATVMNGLEELRVKESDRLSAVA 362 DL VR+S L G+ VP RAPSMIDEYPILAVAAA A G T M+GL ELRVKESDRLSAVA Sbjct: 308 DLEVRASALTGIEVPAARAPSMIDEYPILAVAAACARGTTRMHGLGELRVKESDRLSAVA 367 Query: 363 NGLKLNGVDCDEGETSLVVRGRPDGKGLGNASGAAVATHLDHRIAMSFLVMGLVSENPVT 422 GL GVD +L+V GKG GA VA +LDHRI M+FLV+GLVS VT Sbjct: 368 TGLAACGVDVTVDGDTLIVH----GKGTVPKGGATVAVNLDHRIGMAFLVLGLVSAEAVT 423 Query: 423 VDDATMIATSFPEFMDLMAGLGAKIEL 449 +DD I TSFP F+ LM GLGA I L Sbjct: 424 IDDGRAIDTSFPGFVTLMTGLGAPISL 450 Lambda K H 0.316 0.135 0.380 Gapped Lambda K H 0.267 0.0410 0.140 Matrix: BLOSUM62 Gap Penalties: Existence: 11, Extension: 1 Number of Sequences: 1 Number of Hits to DB: 745 Number of extensions: 40 Number of successful extensions: 3 Number of sequences better than 1.0e-02: 1 Number of HSP's gapped: 1 Number of HSP's successfully gapped: 1 Length of query: 455 Length of database: 451 Length adjustment: 33 Effective length of query: 422 Effective length of database: 418 Effective search space: 176396 Effective search space used: 176396 Neighboring words threshold: 11 Window for multiple hits: 40 X1: 16 ( 7.3 bits) X2: 38 (14.6 bits) X3: 64 (24.7 bits) S1: 41 (21.6 bits) S2: 51 (24.3 bits)
Align candidate WP_011388048.1 RRU_RS01545 (3-phosphoshikimate 1-carboxyvinyltransferase)
to HMM TIGR01356 (aroA: 3-phosphoshikimate 1-carboxyvinyltransferase (EC 2.5.1.19))
# hmmsearch :: search profile(s) against a sequence database # HMMER 3.3.1 (Jul 2020); http://hmmer.org/ # Copyright (C) 2020 Howard Hughes Medical Institute. # Freely distributed under the BSD open source license. # - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - # query HMM file: ../tmp/path.aa/TIGR01356.hmm # target sequence database: /tmp/gapView.2690368.genome.faa # - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - Query: TIGR01356 [M=415] Accession: TIGR01356 Description: aroA: 3-phosphoshikimate 1-carboxyvinyltransferase Scores for complete sequences (score includes all domains): --- full sequence --- --- best 1 domain --- -#dom- E-value score bias E-value score bias exp N Sequence Description ------- ------ ----- ------- ------ ----- ---- -- -------- ----------- 1.4e-121 392.1 0.0 1.6e-121 392.0 0.0 1.0 1 NCBI__GCF_000013085.1:WP_011388048.1 Domain annotation for each sequence (and alignments): >> NCBI__GCF_000013085.1:WP_011388048.1 # score bias c-Evalue i-Evalue hmmfrom hmm to alifrom ali to envfrom env to acc --- ------ ----- --------- --------- ------- ------- ------- ------- ------- ------- ---- 1 ! 392.0 0.0 1.6e-121 1.6e-121 1 414 [. 20 446 .. 20 447 .. 0.94 Alignments for each domain: == domain 1 score: 392.0 bits; conditional E-value: 1.6e-121 TIGR01356 1 geikipgsKSishRalllaaLaegetvvtnlLkseDtlatlealrklGakve.ee....keelviegvgg..l 66 g+i++pg+KSishRal+l++La g+t++++lL++eD++at +a++++Ga++ +e ++++++gvg l NCBI__GCF_000013085.1:WP_011388048.1 20 GRIRVPGDKSISHRALMLGGLAVGRTEIRGLLEGEDVIATAHAMEAMGARIDrQEtadgAGVWTVDGVGVggL 92 79*************************************************85333223468****998888* PP TIGR01356 67 kepeaeldlgnsGttaRlltgvlalasgevvltgdeslkkRPierlveaLrelgaeieskeeegslPlaisgp 139 +ep ++ld+gn+Gt aRll+g+la+++ + +ltgd sl+ RP++r++++L +ga++ ++ g+lP+a++g+ NCBI__GCF_000013085.1:WP_011388048.1 93 AEPADVLDMGNAGTGARLLMGLLATHDLTAILTGDASLRGRPMKRVTDPLALFGASFVGRS-GGRLPMAVRGT 164 ***********************************************************99.59********* PP TIGR01356 140 .lkggivelsgsaSsQyksalllaaplalqavtleivgeklisrpyieitLkllksfgveveeede..rkivv 209 ++++++ + S+Q+ksa+lla+ l++ ++++v+e++ +r+++e++L ++++ ++ ++d+ ++i++ NCBI__GCF_000013085.1:WP_011388048.1 165 aTPLPVSYRVPVPSAQVKSAVLLAG---LNTPGETTVIEPVATRDHTERMLGHFGAA-LRLGRDDQgaTTITL 233 7888*********************...88899999999****************98.999999998888888 PP TIGR01356 210 kggqkykqkevevegDaSsAafflaaaaitge.evtvenlgenstqgdkaiiivLeemGadveveeqr..... 276 +g+ + + vev++D+SsAaf+l+aa++ +e +vt+ ++g+n+++ + +i++L+emGad+ + + r NCBI__GCF_000013085.1:WP_011388048.1 234 TGQPELRAAPVEVPADPSSAAFPLVAAVLVPEsHVTLAGVGMNPQRIG--LIDTLREMGADILIRDPRieage 304 8888855556**********************9***************..888************99999*** PP TIGR01356 277 ...dvevegasklkgvkv.didvdsliDelptlavlaafAegetriknieelRvkEsdRiaaiaeeLeklGve 345 d+ev+ as l g++v ++++s+iDe+p+lav+aa+A+g+tr++++ elRvkEsdR++a+a+ L++ Gv+ NCBI__GCF_000013085.1:WP_011388048.1 305 pvaDLEVR-ASALTGIEVpAARAPSMIDEYPILAVAAACARGTTRMHGLGELRVKESDRLSAVATGLAACGVD 376 ********.899******88***************************************************** PP TIGR01356 346 veeledgllieGkkkelkg.avvdtydDHRiamalavlglaaegeveiedaecvaksfPeFfevleqlga 414 v++ d l+++Gk + kg a+v DHRi ma+ vlgl+ ++ v+i+d ++++sfP F+ ++ lga NCBI__GCF_000013085.1:WP_011388048.1 377 VTVDGDTLIVHGKGTVPKGgATVAVNLDHRIGMAFLVLGLVSAEAVTIDDGRAIDTSFPGFVTLMTGLGA 446 *************8666666999999***************************************99876 PP Internal pipeline statistics summary: ------------------------------------- Query model(s): 1 (415 nodes) Target sequences: 1 (451 residues searched) Passed MSV filter: 1 (1); expected 0.0 (0.02) Passed bias filter: 1 (1); expected 0.0 (0.02) Passed Vit filter: 1 (1); expected 0.0 (0.001) Passed Fwd filter: 1 (1); expected 0.0 (1e-05) Initial search space (Z): 1 [actual number of targets] Domain search space (domZ): 1 [number of targets reported over threshold] # CPU time: 0.01u 0.01s 00:00:00.02 Elapsed: 00:00:00.00 # Mc/sec: 19.32 // [ok]
This GapMind analysis is from Jul 25 2024. The underlying query database was built on Jul 25 2024.
Each pathway is defined by a set of rules based on individual steps or genes. Candidates for each step are identified by using ublast (a fast alternative to protein BLAST) against a database of manually-curated proteins (most of which are experimentally characterized) or by using HMMer with enzyme models (usually from TIGRFam). Ublast hits may be split across two different proteins.
A candidate for a step is "high confidence" if either:
Otherwise, a candidate is "medium confidence" if either:
Other blast hits with at least 50% coverage are "low confidence."
Steps with no high- or medium-confidence candidates may be considered "gaps." For the typical bacterium that can make all 20 amino acids, there are 1-2 gaps in amino acid biosynthesis pathways. For diverse bacteria and archaea that can utilize a carbon source, there is a complete high-confidence catabolic pathway (including a transporter) just 38% of the time, and there is a complete medium-confidence pathway 63% of the time. Gaps may be due to:
GapMind relies on the predicted proteins in the genome and does not search the six-frame translation. In most cases, you can search the six-frame translation by clicking on links to Curated BLAST for each step definition (in the per-step page).
For more information, see:
If you notice any errors or omissions in the step descriptions, or any questionable results, please let us know
by Morgan Price, Arkin group, Lawrence Berkeley National Laboratory